V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Interstitial lung disease
TL;DR: This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.
Journal ArticleDOI
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.
Toby M. Maher,Tamera J. Corte,Tamera J. Corte,Aryeh Fischer,Michael Kreuter,David J. Lederer,Maria Molina-Molina,Judit Axmann,Klaus-Uwe Kirchgaessler,Vincent Cottin +9 more
TL;DR: This double-blind, randomised, placebo-controlled phase II trial is enrolling adults with fibrosing ILD, including uILD that fulfils proposed research criteria for interstitial pneumonia with autoimmune features (IPAF), that cannot be classified with moderate or high confidence to any category of ILD following MDT discussion.
Journal ArticleDOI
Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's): A Report on 26 Cases
Charlotte Girard,Pierre-Emmanuel Charles,Benjamin Terrier,Guillaume Bussonne,Pascal Cohen,Christian Pagnoux,Vincent Cottin,Jean-François Cordier,Loïc Guillevin +8 more
TL;DR: It is confirmed that TBSs are severe GPA manifestations that evolve independently of other organ involvements and do not respond to conventional systemic regimens and rituximab may be of interest for SGS management.
Journal ArticleDOI
Acute exacerbation of idiopathic pulmonary fibrosis: International survey and call for harmonisation
Michael Kreuter,Markus Polke,Simon L.F. Walsh,Johannes Krisam,Harold R. Collard,Nazia Chaudhuri,Sergey Avdeev,Jürgen Behr,G Calligaro,Tamera J. Corte,Kevin R. Flaherty,Manuela Funke-Chambour,Martin Kolb,Yasuhiro Kondoh,Toby M. Maher,Maria Molina Molina,António Morais,Catharina C. Moor,Julie Morisset,Carlos Alberto de Castro Pereira,Silvia Quadrelli,Moisés Selman,Argyrios Tzouvelekis,Claudia Valenzuela,Carlo Vancheri,Vanesa Vicens-Zygmunt,Julia Wälscher,Wim A. Wuyts,Marlies S. Wijsenbeek,Vincent Cottin,Elisabeth Bendstrup +30 more
TL;DR: Lack of focussed international guidelines for management of acute exacerbation of IPF results in global variability in prevention, diagnosis and treatment strategies, and global trials are urgently needed to inform international specific guidelines for AE-IPF.
Journal ArticleDOI
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities
Aryeh Fischer,Mary E. Strek,Vincent Cottin,Paul F. Dellaripa,Elana J. Bernstein,Kevin K. Brown,Sonye K. Danoff,Oliver Distler,Nik Hirani,Kirk D. Jones,Dinesh Khanna,Joyce S. Lee,David A. Lynch,Toby M. Maher,Ann B. Millar,Ganesh Raghu,Richard M. Silver,Virginia D. Steen,Elizabeth R. Volkmann,Ronan H Mullan,David N O'Dwyer,Seamas C. Donnelly +21 more
TL;DR: Determining whether a patient has a diagnosis of CTDassociated ILD is important, as this knowledge may impact treatment decisions, guide surveillance for other concomitant clinical features, and help with assessment of prognosis.